Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 187Recruiting 69Terminated 37Unknown 30Active not recruiting 22Withdrawn 10Not yet recruiting 4Suspended 3No longer available 2Enrolling by invitation 2Available 2Approved for marketing 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 26Gastrointestinal 5Breast 5Thoracic 3Gynecologic 3Sarcoma 2Plasma cell 1Other solid neoplasm 1NET 1Endocrine 1Dermatologic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 17Neoplasms 7Colorectal Neoplasms 6Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Mesothelioma 4Prostatic Neoplasms 3Ovarian Neoplasms 3Mesothelioma, Malignant 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2NSCLC 2Melanoma 2Endometrial Neoplasms 2Diabetes Mellitus 2Carcinoma, Transitional Cell 2Vulvar Neoplasms 1Uterine Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomach Neoplasms 1Psoriasis 1Post-Lyme Disease Syndrome 1Pneumonia 1Parkinson Disease 1Pancreatic Neoplasms 1Osteosarcoma 1Obsessive-Compulsive Disorder 1Neoplasms, Squamous Cell 1

Interventions

aldesleukin 1Paclitaxel 1Nivolumab 1Interleukin-2 1Etoposide 1Docetaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Suspended × Prostatic Neoplasms × Thoracic × Clear all
NCT05958199 2025-06-27

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

NextPoint Therapeutics, Inc.

Phase 1 Suspended
131 enrolled
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT03970382 2022-08-18

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

PACT Pharma, Inc.

Phase 1 Suspended
21 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡